Published in Arch Neurol on March 01, 1990
Human sodium channel myotonia: slowed channel inactivation due to substitutions for a glycine within the III-IV linker. J Physiol (1993) 1.90
The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment. Brain (2009) 1.65
Muscle channelopathies and critical points in functional and genetic studies. J Clin Invest (2005) 1.21
Channelopathies of skeletal muscle excitability. Compr Physiol (2015) 0.94
A novel N440K sodium channel mutation causes myotonia with exercise-induced weakness--exclusion of CLCN1 exon deletion/duplication by MLPA. Acta Myol (2011) 0.90
Phenotypic variation of Val1589Met mutation in a four-generation Chinese pedigree with mild paramyotonia congenitia: case report. Int J Clin Exp Pathol (2015) 0.77
Myotonia fluctuans. Arch Neurol (1992) 0.77
Myotonic disorders: A review article. Iran J Neurol (2016) 0.75
The skeletal muscle chloride channel in dominant and recessive human myotonia. Science (1992) 4.28
Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med (1989) 3.32
Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet (2001) 3.27
Membrane changes in cells from myotonia patients. Physiol Rev (1985) 2.38
A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet (1994) 2.22
A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology (2011) 2.09
Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci U S A (2000) 1.97
Adynamia episodica hereditaria with myotonia: a non-inactivating sodium current and the effect of extracellular pH. Muscle Nerve (1987) 1.94
Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations. Neurology (2007) 1.90
Genotype-phenotype correlations in human skeletal muscle sodium channel diseases. Arch Neurol (1993) 1.88
Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2. Neurology (2010) 1.84
Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain (2001) 1.82
Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group. Arch Neurol (1991) 1.78
Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene. Nat Genet (1997) 1.76
Malignant hyperthermia mutation Arg615Cys in the porcine ryanodine receptor alters voltage dependence of Ca2+ release. J Physiol (2000) 1.76
Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months) Neurology (1993) 1.75
Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann Neurol (1994) 1.72
Myotonic dystrophy with no trinucleotide repeat expansion. Ann Neurol (1994) 1.68
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1. Neurology (2010) 1.67
Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet (2000) 1.58
Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature (1990) 1.57
In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand (1997) 1.57
K(+)-aggravated myotonia: destabilization of the inactivated state of the human muscle Na+ channel by the V1589M mutation. J Physiol (1994) 1.54
Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve (2000) 1.50
Hypokalemic periodic paralysis: in vitro investigation of muscle fiber membrane parameters. Muscle Nerve (1984) 1.44
Seizures following carotid endarterectomy. Arch Neurol (1990) 1.42
Long-term benefit from prednisone therapy in Duchenne muscular dystrophy. Neurology (1991) 1.40
Two cases of adynamia episodica hereditaria: in vitro investigation of muscle cell membrane and contraction parameters. Muscle Nerve (1983) 1.39
Different effects on gating of three myotonia-causing mutations in the inactivation gate of the human muscle sodium channel. J Physiol (1995) 1.36
Protein nutrition and liver disease after jejunoileal bypass for morbid obesity. N Engl J Med (1974) 1.36
Myotonia fluctuans. A third type of muscle sodium channel disease. Arch Neurol (1994) 1.33
Hereditary paroxysmal ataxia: response to acetazolamide. Neurology (1978) 1.33
Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromuscul Disord (2003) 1.33
Localization of the gene encoding the alpha 2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families. Hum Mol Genet (1994) 1.32
Ion channels and epilepsy. Am J Med Genet (2001) 1.32
Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology (1994) 1.31
Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience (1989) 1.30
4-Chloro-m-cresol, a potent and specific activator of the skeletal muscle ryanodine receptor. Biochim Biophys Acta (1996) 1.29
Regulation of the purified Ca2+ release channel/ryanodine receptor complex of skeletal muscle sarcoplasmic reticulum by luminal calcium. Pflugers Arch (1996) 1.29
Paramyotonia congenita: the R1448P Na+ channel mutation in adult human skeletal muscle. Ann Neurol (1996) 1.28
A novel SCN4A mutation causing myotonia aggravated by cold and potassium. Hum Mol Genet (1993) 1.26
Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis. Hum Mol Genet (2001) 1.25
Deletion and conversion in spinal muscular atrophy patients: is there a relationship to severity? Ann Neurol (1997) 1.23
Role in fast inactivation of the IV/S4-S5 loop of the human muscle Na+ channel probed by cysteine mutagenesis. J Physiol (1997) 1.22
Enhanced inactivation and acceleration of activation of the sodium channel associated with epilepsy in man. Eur J Neurosci (2001) 1.19
Quantitative analysis of the "warm-up" phenomenon in myotonic dystrophy type 1. Muscle Nerve (2005) 1.18
Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants. Neurology (2004) 1.17
A reduced K+ current due to a novel mutation in KCNQ2 causes neonatal convulsions. Ann Neurol (1999) 1.17
A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy. Arch Neurol (1991) 1.16
Active fascial contractility: Fascia may be able to contract in a smooth muscle-like manner and thereby influence musculoskeletal dynamics. Med Hypotheses (2005) 1.16
Overexcited or inactive: ion channels in muscle disease. Cell (1995) 1.15
Hypertrophy of the calf with S-1 radiculopathy. Arch Neurol (1988) 1.14
Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone. Arch Neurol (1987) 1.14
Drug-induced myotonia in human intercostal muscle. Muscle Nerve (1988) 1.13
The resting membrane parameters of human intercostal muscle at low, normal, and high extracellular potassium. Muscle Nerve (1984) 1.10
Muscle Na+ channelopathies: MRI detects intracellular 23Na accumulation during episodic weakness. Neurology (2006) 1.10
Effect of prednisone on protein metabolism in Duchenne dystrophy. Am J Physiol (1995) 1.09
Altered sodium channel behaviour causes myotonia in dominantly inherited myotonia congenita. Neuromuscul Disord (1991) 1.08
Calcium currents and transients of native and heterologously expressed mutant skeletal muscle DHP receptor alpha1 subunits (R528H) FEBS Lett (1998) 1.07
Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol (1995) 1.06
Adynamia episodica hereditaria: what causes the weakness? Muscle Nerve (1989) 1.05
Membrane defects in paramyotonia congenita with and without myotonia in a warm environment. Muscle Nerve (1981) 1.05
A sodium channel mutation causing epilepsy in man exhibits subtle defects in fast inactivation and activation in vitro. J Physiol (2000) 1.05
Voltage-activated calcium signals in myotubes loaded with high concentrations of EGTA. Biophys J (2003) 1.05
Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy. Neurology (1999) 1.03
Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle. J Biol Chem (1997) 1.02
Paramyotonia, potassium-aggravated myotonias and periodic paralyses. 37th ENMC International Workshop, Naarden, The Netherlands, 8-10 December 1995. Neuromuscul Disord (1997) 1.02
Clinical investigation of Duchenne muscular dystrophy. A methodology for therapeutic trials based on natural history controls. Arch Neurol (1987) 1.02
Evaluation of pulmonary function in neuromuscular disease. Arch Neurol (1981) 1.01
Role in fast inactivation of conserved amino acids in the IV/S4-S5 loop of the human muscle Na+ channel. Neurosci Lett (1996) 1.01
On identification of Na(+) channel gating schemes using moving-average filtered hidden Markov models. Eur Biophys J (1999) 1.01
Sodium (23Na) MRI detects elevated muscular sodium concentration in Duchenne muscular dystrophy. Neurology (2011) 1.00
Characteristics of Na+ channels and Cl- conductance in resealed muscle fibre segments from patients with myotonic dystrophy. J Physiol (1990) 1.00
Decreased insulin sensitivity of forearm muscle in myotonic dystrophy. J Clin Invest (1978) 1.00
Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation. Neurology (2005) 1.00
External tetraethylammonium as a molecular caliper for sensing the shape of the outer vestibule of potassium channels. Biophys J (1999) 0.99
Cromakalim (BRL 34915) restores in vitro the membrane potential of depolarized human skeletal muscle fibres. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.98
The National Aeronautics and Space Administration-U.S. Public Health Service Health Evaluation and Enhancement Program. Summary of results. Am J Cardiol (1972) 0.98
Proof of a non-functional muscle chloride channel in recessive myotonia congenita (Becker) by detection of a 4 base pair deletion. Hum Mol Genet (1994) 0.98
Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection. Muscle Nerve (1985) 0.98
Familial cramp due to potassium-aggravated myotonia. J Neurol Neurosurg Psychiatry (1998) 0.98
Fura-2 detected myoplasmic calcium and its correlation with contracture force in skeletal muscle from normal and malignant hyperthermia susceptible pigs. Pflugers Arch (1988) 0.97
Expression and functional characterization of the cardiac L-type calcium channel carrying a skeletal muscle DHP-receptor mutation causing hypokalaemic periodic paralysis. Pflugers Arch (1996) 0.96
Effects of temperature and mexiletine on the F1473S Na+ channel mutation causing paramyotonia congenita. Pflugers Arch (1998) 0.96
A novel sodium channel mutation causing a hyperkalemic paralytic and paramyotonic syndrome with variable clinical expressivity. Neurology (1997) 0.96
Activation of the skeletal muscle ryanodine receptor by suramin and suramin analogs. Mol Pharmacol (1996) 0.96
SCN4A-associated hypokalemic periodic paralysis merits a trial of acetazolamide. Neurology (2004) 0.95
Mitochondrial encephalomyopathy with decreased succinate-cytochrome c reductase activity. Neurology (1984) 0.94
Evidence for linkage of the central core disease locus to the proximal long arm of human chromosome 19. Genomics (1991) 0.94
Electrical myotonia in heterozygous carriers of recessive myotonia congenita. Muscle Nerve (1999) 0.94
Novel muscle chloride channel mutations and their effects on heterozygous carriers. Am J Hum Genet (1996) 0.93
Transient weakness and altered membrane characteristic in recessive generalized myotonia (Becker). Muscle Nerve (1988) 0.93
Linkage data suggesting allelic heterogeneity for paramyotonia congenita and hyperkalemic periodic paralysis on chromosome 17. Hum Genet (1991) 0.93
Effects of brief starvation on muscle amino acid metabolism in nonobese man. J Clin Invest (1976) 0.93